DelveInsight’s “KJX839 Inclisiran Drug Insight Market, 2020” highlights the detailed overview, R&D activities, Competitive analysis, and Market assessment around KJX839 (Inclisiran). The report also provides product description, clinical trial analysis, other developmental activities such as merges, acquisitions, collaborations etc., as well as patent details.
Inclisiran Overview
Inclisiran is a long-acting, small-interfering RNA (siRNA) administered twice a year as a subcutaneous injection. It is in development for atherosclerotic cardiovascular disease and primary hyperlipidemia (including familial hypercholesterolemia) for patients who have already had an event like a heart attack or stroke, or who risk-equivalent are. Pivotal Phase III trial results were presented at the European Society of Cardiology Congress and the American Heart Association Scientific Sessions in 2019 by the Medicines Company, prior to its acquisition by Novartis.
For Free Sample Copy @ https://www.delveinsight.com/sample-request/inclisiran-emerging-insight-market-forecast
List of regions involved in the report
Inclisiran Drug Insight Market: Report
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Secondary sources information and data have been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations, SEC filings, Annual Reports, HTA assessment portals, and access to available databases.
Inclisiran Drug Insight Market Analysis
This report provides the historical as well as the forecasted sales of KJX839 (Inclisiran) from 2017 to 2030.
Inclisiran Drug Insight Market Forecast
The product details covers mechanism of action, dosage and administration, route of synthesis, and pharmacological studies, including product marketed details, regulatory milestones, and other development activities. Further, it also consists of market assessments inclusive of the market forecast, SWOT analysis, and detailed analyst views. It further highlights the market competitors, late-stage emerging therapies, and patent details in the global space.
Inclisiran Drug Insight Market Methodology
The report is built using data and information sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and nonprintable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Inclisiran Drug Insight Market Analytical Perspective
This report provides a detailed market assessment of Inclisiran in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. This segment of the report provides historical and forecasted sales data from 2017 to 2030.
The report provides the clinical trials information of Inclisiran covering trial interventions, trial conditions, trial status, start and completion dates.
Inclisiran Drug Insight Market Report Scope
Read TOC
1. Product Overview
2. SWOT Analysis
3. Regulatory Milestones
4. Market Assessment
5. Market Competitors
6. Emerging Therapies
7. Appendix
Inclisiran Drug Insight Market Report Highlights
Key Questions answered in the report
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/